European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Posted on: 26/04/2018 - 13:27

Vaccines matter for each of us: yearly, they prevent 2.7 million people from contracting measles, one million from getting whooping cough and two million babies from getting tetanus. They eradicated smallpox. They stopped polio, a dreadful disease affecting millions of children, in almost all... more

Field of Interest: European Union Medical News
Type: News Feed

Human medicines European public assessment report (EPAR): Vyndaqel, tafamidis, Date of authorisation: 16/11/2011, Revision: 32, Status: Authorised

Submitted by Anonymous (not verified) on 3 June 2026 - 11:34

Human medicines European public assessment report (EPAR): Vyndaqel, tafamidis, Date of authorisation: 16/11/2011, Revision: 32, Status: Authorised

Human medicines European public assessment report (EPAR): Nexium Control, esomeprazole, Date of authorisation: 26/08/2013, Revision: 21, Status: Authorised

Submitted by Anonymous (not verified) on 3 June 2026 - 11:22

Human medicines European public assessment report (EPAR): Nexium Control, esomeprazole, Date of authorisation: 26/08/2013, Revision: 21, Status: Authorised

Updates to industry contact management for authorisation products (IRIS), Online, European Medicines Agency, Amsterdam, the Netherlands, from 11 June 2026, 11:00 (CEST) to 11 June 2026, 12:15 (CEST)

Submitted by Anonymous (not verified) on 3 June 2026 - 9:38

Updates to industry contact management for authorisation products (IRIS), Online, European Medicines Agency, Amsterdam, the Netherlands, from 11 June 2026, 11:00 (CEST) to 11 June 2026, 12:15 (CEST)

Human medicines European public assessment report (EPAR): Theralugand, lutetium (177Lu) chloride, Date of authorisation: 22/11/2024, Revision: 2, Status: Authorised

Submitted by Anonymous (not verified) on 2 June 2026 - 15:55

Human medicines European public assessment report (EPAR): Theralugand, lutetium (177Lu) chloride, Date of authorisation: 22/11/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Orkambi, lumacaftor,ivacaftor, Date of authorisation: 19/11/2015, Revision: 39, Status: Authorised

Submitted by Anonymous (not verified) on 2 June 2026 - 15:46

Human medicines European public assessment report (EPAR): Orkambi, lumacaftor,ivacaftor, Date of authorisation: 19/11/2015, Revision: 39, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness